Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

investors.pfizer.com

Pfizer Inc. Press Releases

Get the latest updates from Pfizer Inc. Press Releases directly as they happen.

Follow now 206 followers

Latest posts

Last updated 5 days ago

XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence

5 days ago

Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI™ in Hemophilia A or B with Inhibitors

19 days ago

Pfizer Declares Third-Quarter 2025 Dividend

20 days ago

Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts

20 days ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

about 1 month ago

Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

about 2 months ago

Pfizer Enters into Exclusive Licensing Agreement with 3SBio

about 2 months ago

Pfizer Enters into Exclusive Licensing Agreement with 3SBio

about 2 months ago

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

3 months ago

Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance

3 months ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

3 months ago

Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer

3 months ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now